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A
 
BSTRACT
Background:
 
Signal transducers and activators of
transcription 6 (Stat6) is a key transcription factor
involved in interleukin (IL)-4 and IL-13-mediated
biological responses. Recently, we reported the associ-
ation between the dinucleotide (GT) repeat poly-
morphism in the first exon of 
 
Stat6
 
 and allergic
subjects in a Japanese population. The aim of the
present study was to evaluate whether this GT repeat
polymorphism is associated with bronchial asthma,
including childhood asthma and atopic and non-
atopic adult asthma.
 
Methods:
 
Stat6
 
 gene polymorphisms were genotyped
by polymerase chain reaction (PCR) fragment length
polymorphism analysis.
 
Results:
 
In the first exon of 
 
Stat6
 
, polymorphic PCR
products were classified into six alleles (12–17 GT
repeats). A significant difference was found in the gen-
otypic frequency of the GT repeat polymorphism
between controls and child asthmatics (
 
P
 
 = 0.015),
but not atopic or non-atopic adult asthma. The
frequency of the 15 repeat allele (wild type) was lower
in child asthmatics than in controls (
 
P
 
 = 0.0047;
odds  ratio (OR) 1.6, 95% confidence interval (CI)
1.16–2.23), whereas shorter repeat alleles (12, 13
and 14 GT repeat) were higher in child asthmatics
than in controls (
 
P
 
 = 0.0064; OR (95%CI) 1.66
(1.15–2.39)).
 
Conclusion:
 
Genetic variations in the 
 
Stat6
 
 gene may
be associated with a predisposition for childhood
asthma.
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I
 
NTRODUCTION
 
Allergic diseases may be based on an inflammatory
mechanism involving Th2 cytokines, such as interleukin
(IL)-4 and IL-13.
 
1,2
 
 When IL-4 or IL-13 engages its
receptor complex, the phosphorylation, dimerization and
nuclear localization of the signal transducer and activa-
tor of transcription 6 (Stat6) results in the transcription of
several IL-4-inducible genes
 
3–5
 
 that play a central role in
IgE synthesis and the development of bronchial hyper-
responsiveness.
 
2,6,7
 
Recently, various genetic studies have shown that
polymorphisms in genetic variations of Th2 cytokines are
associated with atopic disorders in Western or Japanese
populations.
 
8–11
 
 Recently, we reported the association
between the dinucleotide repeat polymorphism of the
 
Stat6
 
 exon 1 and allergic subjects in a Japanese popula-
tion.
 
12
 
 However, other groups have not replicated this
finding; it was demonstrated that the GT repeat did not
show a linkage/association to asthma in a Caucasian
sib-pair study.
 
13
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The aim of the present study was to test whether the GT
repeat polymorphism of the 
 
Stat6
 
 exon 1 relates to bron-
chial asthma, including childhood asthma and atopic or
non-atopic adult asthma, in a Japanese population.
 
M
 
ETHODS
 
Bronchial asthma and control subjects
 
Bronchial asthma and control subjects were collected
in accordance with methods described previously.
 
10,11
 
Briefly, adult and child asthmatic subjects in a Japanese
population were diagnosed by physicians specializing in
asthma, as having: (i) recurrent breathlessness and chest
tightness requiring continuing treatment; (ii) physician-
documented wheeze; and (iii) documented labile airflow
obstruction with variability in serial peak expiratory flow
rates > 30%. Because wheezing is often associated with
viral respiratory infection in young children, children
older than 3 years of age were evaluated for childhood
asthma. Specific IgE was detected by MAST (Hitachi,
Tokyo, Japan) or CAP-RAST (Pharmacia, Uppsala,
Sweden). Atopy was diagnosed as the presence of a
high concentration of total serum IgE (> 250 IU/mL),
a positive specific IgE titer (> 4.41 LC in MAST and
> 0.70 UA/mL in CAP-RAST) against one or more of 15
highly purified aeroallergens or a combination of these
two features. Control subjects were 166 individuals with
no history of major atopic disease. Informed consent
was obtained from all subjects or their parents. This
study was approved by the Committee of Ethics at the
Department of Pediatrics, The University of Gunma.
 
Molecular methods
 
DNA was extracted from peripheral blood leukocytes.
Polymerase chain reaction (PCR) primer sequences in
the first exon of the 
 
Stat6
 
 gene and the PCR conditions
used were as described previously.
 
12
 
 Briefly, PCR reac-
tions were performed in a volume of 25 
 
µ
 
L containing
50 ng genomic DNA, each dNTP at 125 
 
µ
 
mol/L, 2 U
 
Taq
 
 polymerase, 
 
Taq
 
 buffer and 10 pmol forward and
reverse primer. 6-Carboxy fluorescein (6-FAM)-labeled
forward primer was used for 
 
Stat6
 
 exon 1. Cycle
conditions were 95
 
°
 
C for 5 min, followed by 40 cycles
of 95
 
°
 
C for 30 s, 66
 
°
 
C for 30 s and 72
 
°
 
C for 30 s, with
a final extension step of 7 min at 72
 
°
 
C in a GeneAmp
2400 thermocycler (Perkin Elmer, Norwalk, CA, USA).
After PCR, a 1 
 
µ
 
L aliquot of the products plus 0.5 
 
µ
 
L
Genescan 400HD molecular weight standard (Applied
Biosystems, Foster City, CA, USA) were denatured in
12 
 
µ
 
L formamide, separated in an Applied Biosystems
Prism Genetic Analyzer (ABI PRISM
 
TM
 
310) with perform-
ance optimized polymer 6 (POP6) polymer and fragment
lengths determined.
 
Statistical analysis
 
Data were analyzed by the Chi-squared test. 
 
P <
 
 0.05
was considered significant.
 
R
 
ESULTS
 
Children or adults with bronchial asthma and controls
were genotyped in terms of the GT repeat polymorphism
in the first exon of the 
 
Stat6
 
 gene. The allelic and
genotypic distributions of the GT repeat polymorphism
are shown in Tables 1,2. In the first exon of 
 
Stat6
 
,
polymorphic PCR products were classified into six alleles
(12–17 GT repeats; Table 1). The frequency of the 15
GT repeat allele was significantly lower in child asth-
matics compared with controls (odds ratio (OR) 1.6;
95% confidence interval (CI) 1.16–2.23; 
 
P
 
 = 0.0047),
whereas the frequency of shorter repeat alleles (12, 13
and 14 repeats) were significantly higher in child asth-
matics than in controls (OR (95%CI) 1.66 (1.15–2.39);
 
P
 
 = 0.0064). However, there was no significant differ-
ence between atopic or non-atopic adult asthmatics and
controls.
We designated an individual homozygous for the most
commonly occurring allele (the 15 GT repeat allele) as a
wild type, an individual without a shorter repeat allele as
a mutant 1 type and an individual having one or two
shorter repeat alleles as a mutant 2 type (Table 2). There
was a significant difference in the GT repeat poly-
morphism in genotype frequencies between controls and
 
Table 1
 
Allele frequency of GT repeat polymorphisms in
 
Stat6
 
 exon 1
No. GT 
repeats
Controls Asthmatics
Children Atopic 
adults
Non-atopic 
adults
12 0 1 0 0
13 69 79 29 42
14 1 6 0 0
15 222 156** 78 134
16 40 37 11 21
17 0 1 0 1
Total 332 280 118 198
 
**
 
P
 
 < 0.01 compared with controls.
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child asthmatics (
 
P
 
 = 0.011), but not atopic and non-
atopic adult asthmatics (Table 2). Furthermore, a signifi-
cant difference was observed between child asthmatics
and non-atopic adult asthmatics (
 
P
 
 = 0.049). The
frequency of an individual with a mutant 2 type was
significantly higher in child asthmatics than in controls
(OR (95%CI) 1.87 (1.18–2.96); 
 
P
 
 = 0.0072). In con-
trast, no significant difference was observed between
atopic or non-atopic adult asthmatics and controls.
 
D
 
ISCUSSION
 
We found that the GT repeat polymorphism in the first
exon of 
 
Stat6
 
 was significantly associated with childhood
asthma, but not with atopic or non-atopic adult asthma.
The frequency of a shorter repeat allele in child asthmat-
ics was significantly different from those of controls. Our
data suggest that the GT repeat polymorphism in the
 
Stat6
 
 gene may play an important role in the develop-
ment of childhood asthma in the Japanese population.
Despite intensive efforts and advances in molecular
biology and genetics, no gene has been identified with
any certainty as being involved in the heritability of
asthma. However, the results of several studies have pro-
vided an indication that multiple genes may be involved
in its pathogenesis. Recently, we found a novel dinucle-
otide repeat polymorphism in the first exon sequences
of the 
 
Stat6
 
 gene and identified a strong association
between the 13/15 allele heterozygote and allergic dis-
eases.
 
12
 
 The present study further evaluated whether this
GT repeat polymorphism is associated with bronchial
asthma and we have found a significant difference in
allelic and genotypic frequencies in the GT repeat poly-
morphism between child asthmatics and controls, when
considered as a wild or mutant type, suggesting that the
GT repeat variant of the 
 
Stat6
 
 exon 1 is associated with
childhood asthma. Duetsch 
 
et al.
 
13
 
 found that there was
a significant association of the 16 repeats allele with an
increase in the eosinophil cell count. However, they
found that there was no linkage of any of the GT repeat
alleles with the asthmatic phenotype.
 
13
 
 The discrepancy
between the results of Duetsch 
 
et al.
 
13
 
 and the present
study may be explained by the different allelic dis-
tributions between different ethnic groups and different
phenotypes of asthmatic patients. In fact, the frequency
of 13 GT repeat allele was shown to be 40.14% in a
Caucasian population,
 
13
 
 whereas it was 20.8 and 28.2%
in controls and child asthmatics, respectively, in the
Japanese population in the present study. Furthermore,
we evaluated patients divided by age and the level of IgE,
whereas Duetsch 
 
et al.
 
13
 
 used sib-pair analysis.
In the present study, we found that the frequency of
shorter repeat alleles of the 
 
Stat6
 
 exon 1 were signifi-
cantly higher in child asthmatics than in controls. In
addition, the genotypic frequency of an individual with a
mutant 2 type was significantly higher in child asthmatics
than controls. The GT repeat polymorphism of 
 
Stat6
 
 may,
directly or indirectly, modulate 
 
Stat6
 
 gene expression.
Perhaps the repeat number may be an important factor
for this modulation (e.g. a shorter repeat allele than a
wild type enhances the function, whereas the longer
repeats do not, and vice versa).
Interestingly, in the present study we could not identify
a linkage with either atopic or non-atopic adult asthma.
In Japanese people, less than 20% of adult asthma is a
type developed during childhood. There seems to be
some difference in the pathogenesis (especially genetic
background) between adult asthma developed during
childhood and adult-onset asthma, although no con-
clusion has been reached. We need to extend the
association studies further to ascertain any differences in
pathogenesis between these two types of asthma. More
 
Table 2
 
Association between genotypic distribution of GT repeat polymorphisms in 
 
Stat6
 
 exon 1 and asthma
Phenotype No. cases Genotype of GT repeat
 
P
 
 
 
P
 
†
 
OR
 
†
 
 (95%CI)
No. wild type 
(%)
No. mutant 1 
(%)
No. mutant 2 
(%)
Control 166 76 (45.8) 30 (18.1) 60 (36.1)
Asthmatics
Children 140 42 (30) 26 (18.6) 72 (51.4) 0.011 0.0072 1.87 (1.18–2.96)
Atopic adults 59 23 (39.0) 8 (13.6) 28 (47.5) 0.300 0.126
Non-atopic adults 99 45 (45.5) 15 (15.2) 39 (39.4) 0.783 0.597
 
†
 
Wild type + mutant 1 compared with mutant 2.
Wild type, wild/wild homozygosity; mutant 1, longer/longer, longer/wild; mutant 2, shorter/shorter, shorter/wild, shorter/longer. (Wild: 15 GT
repeats; shorter: 12, 13 and 14 GT repeats; longer: 16 and 17 GT repeats.) OR, odds ratio; CI, confidence interval.
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than 90% of childhood asthma is of the atopic type,
whereas two-thirds of adult asthma consists of infectious
or mixed types. Moreover, childhood asthma contributes
anti-IgE antibodies to environmental allergens, such as
house dust mites and animal dander. Thus, there are
some features that make adult-onset asthma different to
that seen in younger patients. Our results suggest that the
relative contribution of genetic and environmental factors
in the pathogenesis of asthma may vary according to
age. It has been reported, with respect to the Ile50Val
variant in the IL-4 receptor 
 
α
 
, that Ile50 was associated
with atopic asthma but not with non-atopic subjects and
that this association was especially strong in children.
 
10
 
These results seem to be somewhat consistent with those
of the present study showing that the 
 
Stat6
 
 gene variant
was significantly associated with childhood asthma,
although we could not identify a linkage with atopic adult
asthma. We previously found that IgE production was not
associated with the 
 
Stat6
 
 gene.
 
12 Furthermore, because
Duetsch et al.13 failed to demonstrate a relationship
between the level of serum IgE and Stat6 gene variants in
Caucasian asthma patients,13 it is unlikely that the Stat6
gene variants promote the dysregulation of IgE synthesis.
Our findings suggest that the polymorphic micro-
satellite at the Stat6 locus may be a useful marker for
predicting future childhood asthma and, thus, allow
for early therapeutic intervention in cases of high-risk
infants. Because asthma is a multifactorial disease, char-
acterized by high genetic heterogeneity between different
ethnic groups, it is possible that the influence of Stat6 on
asthma differs according to the population. Additional
genetic and epidemiological studies, as well as functional
analysis of Stat6, are required to fully elucidate the role of
this interesting gene in the development of asthma.
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